KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Johnson & Johnson (JNJ) over the last 17 years, with Q4 2025 value amounting to $63.0 million.

  • Johnson & Johnson's Gains from Investment Securities fell 1250.0% to $63.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $162.0 million, marking a year-over-year decrease of 689.66%. This contributed to the annual value of $162.0 million for FY2025, which is 689.66% down from last year.
  • As of Q4 2025, Johnson & Johnson's Gains from Investment Securities stood at $63.0 million, which was down 1250.0% from $33.0 million recorded in Q3 2025.
  • In the past 5 years, Johnson & Johnson's Gains from Investment Securities registered a high of $297.0 million during Q3 2021, and its lowest value of -$185.0 million during Q1 2023.
  • Its 5-year average for Gains from Investment Securities is $36.0 million, with a median of $33.0 million in 2025.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first crashed by 8558.56% in 2024, then surged by 50000.0% in 2025.
  • Johnson & Johnson's Gains from Investment Securities (Quarter) stood at $16.0 million in 2021, then skyrocketed by 268.75% to $59.0 million in 2022, then crashed by 276.27% to -$104.0 million in 2023, then surged by 169.23% to $72.0 million in 2024, then fell by 12.5% to $63.0 million in 2025.
  • Its Gains from Investment Securities stands at $63.0 million for Q4 2025, versus $33.0 million for Q3 2025 and $36.0 million for Q2 2025.